Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 15, 2018
Symtuza<sup>®</sup> in clinical practiceJosé Luis Casado, María Fontecha, Marta Monsalvo, et al.Expert Review of Clinical Pharmacology|May 19, 2018
Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infectionJose L Casado, Marta Monsalvo, Aurora M Rojo, et al.Antiviral Therapy|June 8, 2019
Efficacy and safety of dolutegravir plus boosted-darunavir dual therapy among highly treatment-experienced patientsPilar Vizcarra, María Fontecha, Marta Monsalvo, et al.International Journal of STD & AIDS|April 10, 2019
CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatmentMarta Monsalvo, Alejandro Vallejo, María Fontecha, et al.Infectious Diseases (London, England)|February 8, 2019
Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavirMaría Fontecha, Marta Monsalvo, Miguel A Rodriguez-Sagrado, et al.HIV Research & Clinical Practice|July 16, 2019
Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical settingJose L Casado, Marta Monsalvo, María Fontecha, et al.Pageof 1